Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymeric contrast agents for medical imaging.

V P Torchilin1

  • 1Department of Pharmaceutical Science, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, MA 02115, USA.

Current Pharmaceutical Biotechnology
|July 27, 2001
PubMed
Summary

Synthetic polymers enhance diagnostic imaging by acting as carriers for contrast agents. These novel polymers improve imaging quality and speed across gamma, MR, and CT modalities, benefiting various medical applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

siRNA based drug design, quality, delivery and clinical translation.

Nanomedicine : nanotechnology, biology, and medicine·2020
Same author

Efficient nanocarriers of siRNA therapeutics for cancer treatment.

Translational research : the journal of laboratory and clinical medicine·2019
Same author

MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation.

Journal of drug targeting·2019
Same author

Double-targeted polymersomes and liposomes for multiple barrier crossing.

International journal of pharmaceutics·2016
Same author

Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid.

Oncogene·2015
Same author

Hypoxia-targeted siRNA delivery.

Angewandte Chemie (International ed. in English)·2014

Area of Science:

  • Polymer chemistry and materials science
  • Medical imaging and diagnostics
  • Nanotechnology for drug delivery

Background:

  • Contrast agents are crucial for medical imaging (gamma, MR, CT).
  • Existing contrast agents have limitations in loading capacity and circulation time.
  • Development of advanced polymer carriers is needed to improve imaging performance.

Purpose of the Study:

  • To synthesize and characterize novel synthetic polymers and co-polymers for use as carriers in diagnostic imaging.
  • To enhance the loading of reporter metal atoms and contrast agents within these polymer structures.
  • To evaluate the efficacy of these polymer-based contrast agents in improving image quality and reducing imaging time.

Main Methods:

  • Synthesis of single terminus-activated polychelating polymers using poly-L-lysine (PLL) with chelating side groups (e.g., DTPA).

Related Experiment Videos

  • Modification of diagnostic monoclonal antibodies with these polymers to increase reporter metal atom load.
  • Development of amphiphilic polymers by modifying polychelating polymers with hydrophobic phospholipid residues for liposome and micelle incorporation.
  • Synthesis of a block-copolymer (MPEG-iodine-PLL) for CT contrast agents, forming iodine-loaded micelles.

    • Main Results:

    • Polymer-modified antibodies showed improved imaging in animal experiments, with better images obtained in shorter times.
    • Amphiphilic polymers significantly increased the loading of contrast agents in liposomes and micelles, enhancing imaging of vascular and lymphatic systems.
    • A novel MPEG-PLL block-copolymer formed stable micelles with high iodine content (up to 30% by weight), successfully visualizing the vascular network in CT imaging.

    Conclusions:

    • Synthetic polychelating and amphiphilic polymers are effective carriers for diagnostic imaging agents.
    • These polymers enhance reporter metal loading and improve imaging performance across multiple modalities.
    • The developed contrast agents offer potential for faster, higher-quality diagnostic imaging in clinical and experimental medicine.